Patent US4313786A successfully refreshed from Google Patents.
Patent US5567415A successfully refreshed from Google Patents.
US5567415A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Ultrasound contrast agents and methods for their manufacture and use
Assignee: University of Nebraska System
•
Filing: 1994-06-01
•
Granted: 1996-10-22
•
Expires: 2014-06-01
Abstract
Abstract This invention relates to a new ultrasound contrast agent of the type which relies on microbubbles for echogenicity. The improvement comprises enhancing the internal atmosphere of the microbubbles with an amount of perfluoropropane which is effective for visually detecting myocardial uptake upon echocardiogram following peripheral intravenous injection of said agent into a host. The contrast agent of this invention is unique in that it makes possible the non-invasive visual detection of myocardial uptake. In addition, the contrast agent of this invention makes feasible safe and consistent, non-invasive methods for visually assessing, qualitatively or quantitatively, not only myocardial perfusion, but renal and hepatic perfusion, and for detecting severity of coronary arterial stenosis. the invnetion also relates to a method of ultrasonic imaging for use in medical procedures, comprising the steps of injecting perfluoropropane-containing microbubbles into a mammal to thereby alter the acoustic properties of a predetermined area, and ultrasonically scanning an area including said predetermined area so as to obtain an image of said predetermined area.
Inventors
- 👤 Thomas R. Porter
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 03:06
CPC Classifications
A; A61; A61K; A61K49/00; A61K49/22; A61K49/222; A61K49/223
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
54 words
A pharmaceutically acceptable ultrasound contrast agent which relies on microbubbles for echogenicity, comprising: microbubbles with an internal atmosphere enhanced with an amount of perfluoropropane gas which is effective for visually detecting myocardial contrast, said microbubbles formed from a solution of dextrose and albumin wherein said dextrose comprises about 3.75% by weight of said solution.
Claim 2
Dependent Claim
54 words
A pharmaceutically acceptable ultrasound contrast agent which relies on microbubbles for echogenicity, comprising: microbubbles with an internal atmosphere enhanced with an amount of perfluoropropane gas which is effective for visually detecting myocardial contrast, said microbubbles formed from a solution of dextrose and albumin wherein said dextrose comprises about 3.75% by weight of said solution.
Claim 3
Dependent Claim
50 words
An ultrasound contrast agent comprising: a sonicated aqueous albumin-dextrose solution wherein said dextrose comprises less than about 40% by weight of said solution and microbubbles with a perfluorocarbon gaseous content which is effective for visually detecting myocardial perfusion upon echocardiogram following peripheral intravenous injection of said agent into a host.
Claim 4
Dependent Claim
50 words
An ultrasound contrast agent comprising: a sonicated aqueous albumin-dextrose solution wherein said dextrose comprises less than about 40% by weight of said solution and microbubbles with a perfluorocarbon gaseous content which is effective for visually detecting myocardial perfusion upon echocardiogram following peripheral intravenous injection of said agent into a host.
Claim 5
Independent Claim
67 words
A method of ultrasonic imaging for use in medical procedures, comprising the steps of: (a) injecting perfluoropropane-containing microbubbles in an albumin dextrose solution having less than 40% by weight of said solution comprising dextrose, into a mammal to thereby alter the acoustic properties of a predetermined area, and b) ultrasonically scanning an area including said predetermined area so as to obtain an image of said predetermined area.
Claim 6
Independent Claim
67 words
A method of ultrasonic imaging for use in medical procedures, comprising the steps of: (a) injecting perfluoropropane-containing microbubbles in an albumin dextrose solution having less than 40% by weight of said solution comprising dextrose, into a mammal to thereby alter the acoustic properties of a predetermined area, and b) ultrasonically scanning an area including said predetermined area so as to obtain an image of said predetermined area.
Claim 7
Independent Claim
59 words
A method of making an ultrasonic contrast agent for echocardiographic imaging comprising the steps of: forming an aqueous protein solution containing 3.75% by weight of dextrose, and thereafter subjecting said solution to high frequency sonication while exposing said solution to perfluoropropane gas, said sonication forming stabilized microbubbles of relatively uniform size, containing said perfluoropropane, and capable of transpulmonary passage.
Claim 8
Independent Claim
59 words
A method of making an ultrasonic contrast agent for echocardiographic imaging comprising the steps of: forming an aqueous protein solution containing 3.75% by weight of dextrose, and thereafter subjecting said solution to high frequency sonication while exposing said solution to perfluoropropane gas, said sonication forming stabilized microbubbles of relatively uniform size, containing said perfluoropropane, and capable of transpulmonary passage.
Claim 9
Independent Claim
75 words
A method for myocardial, renal or heptic opacification comprising the following steps: mixing human serum albumin with a solution comprising an aqueous monosaccharide in a ratio of 1:3 to 1:7 respectively to form a solution; sonicating said solution for at least 80 seconds to form microbubbles approximately 3 to 5 microns in diameter, thereby forming an echo contrast agent; intravenously injecting said solution into an animal subject; and detecting the image produced by ultrasound imaging.
Claim 10
Independent Claim
75 words
A method for myocardial, renal or heptic opacification comprising the following steps: mixing human serum albumin with a solution comprising an aqueous monosaccharide in a ratio of 1:3 to 1:7 respectively to form a solution; sonicating said solution for at least 80 seconds to form microbubbles approximately 3 to 5 microns in diameter, thereby forming an echo contrast agent; intravenously injecting said solution into an animal subject; and detecting the image produced by ultrasound imaging.
Claim 11
Dependent Claim
36 words
The contrast agent of claim 2 wherein said mixture comprises between about a 2-fold to about an 8-fold dilution of said human serum albumin with about a 5% to about a 50% solution of aqueous dextrose.
Claim 12
Dependent Claim
17 words
The contrast agent of claim 2 wherein said mixture comprises about a 7-fold dilution of 50% dextrose.
Claim 13
Dependent Claim
17 words
The contrast agent of claim 2 wherein said mixture comprises about a 3-fold dilution of 5% dextrose.
References Cited (Backward Citations)
WO1992005806A1
Cited
US5413774A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-10-22 | 2000-04-22 | 2000-10-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-10-22 | 2004-04-22 | 2004-10-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-10-22 | 2008-04-22 | 2008-10-22 | $7700.00 | Window Closed / Lapsed |